GTx, Inc.

175 Toyota Plaza, Memphis, TN 38103

Public
Healthcare & Pharmaceuticals - Pharmaceuticals
around $2.5 - 5M
around 20 - 50
(901) 523-9700
(901) 844-8075


GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions. As of December 31, 2011, the Company is developing selective androgen receptor modulators (SARMs), a new class of drugs with the potential to prevent and treat muscle wasting in patients with cancer and other musculoskeletal wasting or muscle loss conditions, including chronic sarcopenia (age related muscle loss). It held End of Phase II meetings with the United States Food and Drug Administration, or FDA, prior to initiating its Phase III clinical development of enobosarm for the prevention and treatment of muscle wasting in patients with non-small ce... (Source: SEC reports)


Competitor - 1/7
Which company is more competitive with GTx, Inc.?



No Data to Display.

30 Contacts at this company
Chris Coss Research Assistant Professor The Ohio State ...
Chris Coss Research Assistant Professor The Ohio State
Lauren Crosby
Associate Director of Accounting, SEC ...
Chien-Ming Li
Senior Scientist
Jaylyn Victoria
Medical Science Liaison
Ramesh Narayanan
Associate Professor, Department of ...
Robert Wills
Executive Chairman
Chuck Trisdale
IS Secusrity Manager
JoAnn Starcevic
Administrative Assistant
Mark Mosteller
VP, CFO

Feb 22, 2018 19:18:41
MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today announced the acceptance of an abstract on clinical results from an ongoing, open-label, Phase 2  [...]

Feb 22, 2018 17:30:33
MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today announced the acceptance of an abstract on clinical results from an ongoing, open-label, Phase 2  [...]

Nov 14, 2017 19:24:15
MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq:GTXI) today reported financial results for the third quarter of 2017 and highlighted recent accomplishments and upcoming  [...]

Nov 14, 2017 17:30:36
MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq:GTXI) today reported financial results for the third quarter of 2017 and highlighted recent accomplishments and upcoming  [...]

Nov 8, 2017 18:54:22
MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Stifel 2017 [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.